Moderator 1: Jimm Grimm, Johns Hopkins University
Moderator 2: Jinyu Xue, NYU Langone Medical Center
|
| Thursday
10:00 AM - 12:00 PM | TH-BC-SAN1-0 : Rationale and Evidence for SBRT
V.Yu*, C.Song*, D.Carlson*, A.Marciscano* |
|
| | 10:00 AM
TH-BC-SAN1-1 | Introduction
|
|
| | 10:05 AM
TH-BC-SAN1-2 | Radiation Therapy Dose Response Modeling and Optimization of Fractionation Schedules with Cancer Stem Cells
V.Yu* |
|
| | 10:30 AM
TH-BC-SAN1-3 | Role of Vascular Damage and Tumor Microenvironment in the Response of Tumors to SBRT and SRS
C.Song* |
|
| | 10:55 AM
TH-BC-SAN1-4 | Biological Dose Escalation and Outcomes Modeling in the Era of Stereotactic Radiotherapy
D.Carlson* |
|
| | 11:20 AM
TH-BC-SAN1-5 | Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities
A.Marciscano* |
|
| | |
